Hong Kong Lemite Group LimitedRetatrutide
Ordered Retatrutide from Hong Kong Lemite Group Limited? Mail in a sample (US only) and let us test it for free.
Test my supplyHong Kong Lemite Group Limited's Retatrutide evidence is held back by a sharp December miss: 98.92% purity, 7.28 mg on a 30 mg claim, and no batch ID. Later samples recovered, but the history remains mixed.
A Hong Kong-facing name, a dead Global Sources listing, and a private China-registrar web trail do not resolve to the counterparty a peptide buyer would want. The report traces the trader profile, source-lab opacity, and absence of a public promoter network.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Hong Kong Lemite Group Limited rows.
Cancel anytime
About Hong Kong Lemite Group Limited test results from Finnrick
Hong Kong Lemite Group Limited is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 4 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Hong Kong Lemite Group Limited peptides in this dataset are Retatrutide (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 4 recent tests.
Ordered Retatrutide from Hong Kong Lemite Group Limited? Mail in a sample (US only) and let us test it for free.
Test my supply